Why I would buy and hold these shares for a decade

When it comes to finding shares to buy and hold for an extended period, I think the healthcare and information technology sectors are great places to start looking.

While there are a large number of quality options in both sectors, I have picked out my current favourites below.

Here’s why I think they are great buy and hold investment candidates:

Altium Limited (ASX: ALU)

Although its shares have almost tripled in value since this time last year, I still believe that Altium could prove to be a great buy and hold investment. The printed circuit board (PCB) design software provider looks set to be a big winner from the rise of the Internet of Things market. As the majority of devices that connect to the internet require a PCB inside them, I expect demand for Altium’s software will continue to increase significantly.

This increasing demand was evident when Altium released its half-year results last week. The software company reported half-year revenue growth of 30% to US$63.2 million, earnings before interest, tax, depreciation and amortisation growth of 51% to US$19 million, and net profit after tax growth of 51%. I believe this puts it well on course to achieve its revenue target of US$200 million by FY 2020.

CSL Limited (ASX: CSL)

This biopharmaceutical company is my favourite healthcare share on the Australian share market just ahead of private hospital operator Ramsay Health Care Limited (ASX: RHC). I thought CSL’s first-half result was a highlight of earnings season and demonstrated why it could be a stand out buy and hold investment option.

CSL reported a 31% lift in net profit after tax to surpass US$1 billion for the first time in half. This was driven by strong sales from its immunoglobulin and seasonal flu vaccine products. While the second-half is likely to be softer due to seasonal factors, I still expect a stellar full-year result that justifies the premium its shares trade at today.

Looking for more buy and hold investment ideas? Then don't miss out on these stellar blue chip shares with enormous long-term growth potential.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Altium. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.